How to buy Amyris stock (AMRS)

Amyris is a specialty chemicals business based in the US. Amyris shares (AMRS) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $0.04 – a decrease of 10.2% over the previous week. Amyris employs 1,598 staff and has a trailing 12-month revenue of around $268.2 million.

Our top picks for where to buy Amyris stock

Buy Amyris stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Amyris stock price (NASDAQ: AMRS)

Use our graph to track the performance of AMRS stocks over time.

Amyris shares at a glance

• Key figures

Information last updated 2024-06-30.

Latest market close	$0.04
52-week range	$0.00 - $0.00
50-day moving average more info button	$0.58
200-day moving average more info button	$1.11
Wall St. target price	$1.00
PE ratio more info button	N/A
Dividend yield more info button	$0 (0%)
Earnings per share (TTM) more info button	$-1.16

Is it a good time to buy Amyris stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Amyris price performance over time

Historical closes compared with the close of $0.044 from 2023-09-08

1 week (2024-10-16)	N/A
1 month (2024-09-23)	N/A
3 months (2024-07-23)	N/A
6 months (2024-04-23)	N/A

1 year (2023-10-23)	N/A
2 years (2022-10-27)	-98.35%
3 years (2021-10-27)	13.96
5 years (2019-10-25)	3.69

Amyris financials

Revenue TTM	$268.2 million
Gross profit TTM	$-97,736,000
Return on assets TTM	-46.4%
Return on equity TTM	-532.08%
Profit margin	-229.12%
Book value	$-1.80
Market Capitalization more info button	$18.5 million

TTM: trailing 12 months

Amyris share dividends

We're not expecting Amyris to pay a dividend over the next 12 months.

Have Amyris's shares ever split?

Amyris's shares were split on a 1:15 basis on 5 June 2017 . So if you had owned 15 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Amyris shares – just the quantity. However, indirectly, the new 1400% higher share price could have impacted the market appetite for Amyris shares which in turn could have impacted Amyris's share price.

Amyris share price volatility

Over the last 12 months, Amyris's shares have ranged in value from as little as $0 up to $0. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Amyris's is 1.1895. This would suggest that Amyris's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).

Amyris overview

Amyris, Inc. operates as a biotechnology company in Europe, North America, Asia, South America, and internationally. It creates, manufactures, and commercializes consumer products and ingredient, including clean beauty, personal care, and health and wellness consumer products; and ingredients to the flavor and fragrance, nutrition, food and beverage, and clean beauty and personal care end markets. The company markets its products under the Biossance, JVN, Rose Inc. , Pipette, Costa Brazil, OLIKA, Purecane, Terasana, MenoLabs, EcoFabulous, Stripes, and 4U by Tia brand names. It has a collaboration and license agreement with the Infectious Disease Research Institute for the development of a COVID-19 vaccine. The company was formerly known as Amyris Biotechnologies, Inc.

Frequently asked questions

null
What percentage of Amyris is owned by insiders or institutions?
Currently 5.863% of Amyris shares are held by insiders and 54.121% by institutions. How many people work for Amyris?
Latest data suggests 1,598 work at Amyris. When does the fiscal year end for Amyris?
Amyris's fiscal year ends in December. Where is Amyris based?
Amyris's address is: 5885 Hollis Street, EmeryVille, CA, United States, 94608 What is Amyris's ISIN number?
Amyris's international securities identification number is: US03236M2008 What is Amyris's CUSIP number?
Amyris's Committee on Uniform Securities Identification Procedures number is: 03236M101